Protein Official symbol | ADA |
Aliases | ADA ADA1 |
Chromosomal Location | 20 |
Length | 363 |
Uniprot ID | P00813 |
EC number | 3.5.4.4 |
Protein family Information(Pfam) | PF00962; |
PDB id | 1M7M;3IAR; |
InterPro ID | IPR006650;IPR001365;IPR028893;IPR006330;IPR032466; |
dbSNP | rs73598374 rs121908725 rs121908724 rs121908730 rs121908736 rs11555566 rs121908726 rs267606634 rs121908714 rs121908714 rs121908717 rs267606635 rs121908739 rs121908731 rs121908732 rs61732239 rs121908737 rs121908733 rs121908728 rs121908735 rs121908722 rs121908719 rs121908727 rs121908734 rs121908740 rs121908716 rs114025668 rs121908723 rs121908729 rs121908738 rs121908721 rs121908718 rs199422327 rs121908715 |
Protein 1 | Protein 2 | Combine Score |
---|---|---|
ADA | PNP | 0.996 |
ADA | ADK | 0.995 |
PNP | ADK | 0.989 |
NT5C3A | NT5C | 0.979 |
ADA | NT5E | 0.971 |
NT5C2 | DCK | 0.968 |
ADK | NT5E | 0.968 |
PNP | DCK | 0.963 |
ADA | DCK | 0.962 |
CECR1 | PNP | 0.957 |
CECR1 | ADK | 0.956 |
NT5C2 | NT5C1A | 0.956 |
NT5C3A | NT5C2 | 0.952 |
CECR1 | ADA | 0.945 |
PNP | NT5C2 | 0.945 |
NT5C3B | NT5C1B | 0.945 |
NT5C | NT5C1A | 0.944 |
NT5C3A | NT5C1A | 0.944 |
NT5C3B | NT5C1A | 0.944 |
NT5C3A | DCK | 0.943 |
DCK | NT5C | 0.94 |
PNP | NT5E | 0.94 |
NT5M | DCK | 0.938 |
NT5C2 | ADK | 0.937 |
ADA | NT5C2 | 0.935 |
NT5C1B | NT5C | 0.934 |
NT5M | NT5C1A | 0.933 |
DCK | NT5C1A | 0.932 |
NT5C2 | NT5C | 0.932 |
NT5C1B | NT5C2 | 0.931 |
ADA | ADAR | 0.929 |
NT5M | NT5C1B | 0.928 |
NT5C1B | DCK | 0.925 |
NT5M | NT5C2 | 0.923 |
ADK | NT5C1A | 0.923 |
PNP | NT5C1A | 0.923 |
NT5C3A | NT5C1B | 0.921 |
ADA | NT5C1A | 0.921 |
DCK | NT5E | 0.92 |
NT5C3B | PNP | 0.92 |
NT5C3B | NT5C2 | 0.918 |
NT5C3A | PNP | 0.917 |
NT5C3B | ADK | 0.917 |
NT5C3B | DCK | 0.915 |
NT5C3B | NT5M | 0.915 |
ADA | NT5C | 0.914 |
PNP | NT5C | 0.913 |
NT5C1B | ADK | 0.913 |
NT5C3A | ADA | 0.912 |
NT5M | NT5E | 0.911 |
NT5M | ADK | 0.91 |
NT5M | ADA | 0.908 |
NT5C3B | ADA | 0.907 |
NT5C3A | ADK | 0.905 |
ADA | NT5C1B | 0.904 |
RDH14 | ADA | 0.903 |
NT5M | PNP | 0.903 |
ENSG00000250741 | PNP | 0.902 |
PNP | NT5C1B | 0.902 |
ADK | NT5C | 0.902 |
ENSG00000250741 | ADA | 0.9 |
ENSG00000250741 | ADK | 0.9 |
CECR1 | DCK | 0.9 |
NT5C3A | NT5M | 0.9 |
ENSG00000250741 | DCK | 0.9 |
NT5C3B | NT5C | 0.9 |
# | 100 (ADA) | 103 (ADAR) | 132 (ADK) | 1633 (DCK) | 4860 (PNP) | 4907 (NT5E) | 22978 (NT5C2) | 30833 (NT5C) | 51251 (NT5C3A) | 51816 (CECR1) | 56953 (NT5M) | 57665 (RDH14) | 84618 (NT5C1A) | 93034 (NT5C1B) | 115024 (NT5C3B) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
100 (ADA) | 1.00 | 0.71 | 0.26 | 0.36 | 0.38 | 0.27 | 0.51 | 0.28 | 0.40 | 0.80 | 0.22 | 0.18 | 0.57 | 0.27 | 0.57 |
103 (ADAR) | 0.71 | 1.00 | 0.53 | 0.33 | 0.42 | 0.24 | 0.45 | 0.33 | 0.25 | 0.61 | 0.19 | 0.15 | 0.49 | 0.24 | 0.49 |
132 (ADK) | 0.26 | 0.53 | 1.00 | 0.56 | 0.39 | 0.12 | 0.47 | 0.26 | 0.33 | 0.22 | 0.12 | 0.12 | 0.25 | 0.12 | 0.25 |
1633 (DCK) | 0.36 | 0.33 | 0.56 | 1.00 | 0.45 | 0.13 | 0.56 | 0.19 | 0.33 | 0.42 | 0.13 | 0.13 | 0.33 | 0.13 | 0.33 |
4860 (PNP) | 0.38 | 0.42 | 0.39 | 0.45 | 1.00 | 0.15 | 0.37 | 0.35 | 0.30 | 0.33 | 0.13 | 0.15 | 0.37 | 0.15 | 0.37 |
4907 (NT5E) | 0.27 | 0.24 | 0.12 | 0.13 | 0.15 | 1.00 | 1.00 | 1.00 | 1.00 | 0.27 | 1.00 | 0.11 | 1.00 | 1.00 | 1.00 |
22978 (NT5C2) | 0.51 | 0.45 | 0.47 | 0.56 | 0.37 | 1.00 | 1.00 | 0.61 | 0.64 | 0.47 | 0.63 | 0.13 | 0.83 | 1.00 | 0.83 |
30833 (NT5C) | 0.28 | 0.33 | 0.26 | 0.19 | 0.35 | 1.00 | 0.61 | 1.00 | 0.57 | 0.23 | 0.82 | 0.13 | 0.70 | 1.00 | 0.70 |
51251 (NT5C3A) | 0.40 | 0.25 | 0.33 | 0.33 | 0.30 | 1.00 | 0.64 | 0.57 | 1.00 | 0.32 | 0.63 | 0.16 | 0.57 | 1.00 | 0.57 |
51816 (CECR1) | 0.80 | 0.61 | 0.22 | 0.42 | 0.33 | 0.27 | 0.47 | 0.23 | 0.32 | 1.00 | 0.16 | 0.18 | 0.51 | 0.27 | 0.51 |
56953 (NT5M) | 0.22 | 0.19 | 0.12 | 0.13 | 0.13 | 1.00 | 0.63 | 0.82 | 0.63 | 0.16 | 1.00 | 0.13 | 0.75 | 1.00 | 0.75 |
57665 (RDH14) | 0.18 | 0.15 | 0.12 | 0.13 | 0.15 | 0.11 | 0.13 | 0.13 | 0.16 | 0.18 | 0.13 | 1.00 | 0.13 | 0.11 | 0.13 |
84618 (NT5C1A) | 0.57 | 0.49 | 0.25 | 0.33 | 0.37 | 1.00 | 0.83 | 0.70 | 0.57 | 0.51 | 0.75 | 0.13 | 1.00 | 1.00 | 1.00 |
93034 (NT5C1B) | 0.27 | 0.24 | 0.12 | 0.13 | 0.15 | 1.00 | 1.00 | 1.00 | 1.00 | 0.27 | 1.00 | 0.11 | 1.00 | 1.00 | 1.00 |
115024 (NT5C3B) | 0.57 | 0.49 | 0.25 | 0.33 | 0.37 | 1.00 | 0.83 | 0.70 | 0.57 | 0.51 | 0.75 | 0.13 | 1.00 | 1.00 | 1.00 |
Protein Official symbol | Source Organism | Tissue of Expression | Level of hypoxia | Altitude | Duration of experiment | Level of expression | Fold change | Experiment details | geographical location | ethnicity of the patients | Control group | Control (Fold change) | Reference (PMID) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ADA | Bird | Kidney | - | 4000 m | Native | downregulated | -2.05 | Sequencing | Central Asia | L. dichrous (Bird) | 1 | L. dichrous vs. Po. Palustris | 31127049 |
miRTarBase ID | miRNA | Species (miRNA) | Protein Official Symbol | Human Entrez ID | Species (Target Gene) | Experiments | Support Type | References (PMID) |
---|---|---|---|---|---|---|---|---|
MIRT027685 | hsa-miR-98-5p | Homo sapiens | ADA | 100 | Homo sapiens | Microarray | Functional MTI (Weak) | 19088304 |
MIRT041891 | hsa-miR-484 | Homo sapiens | ADA | 100 | Homo sapiens | CLASH | Functional MTI (Weak) | 23622248 |
MIRT438367 | hsa-miR-140-5p | Homo sapiens | ADA | 100 | Homo sapiens | Luciferase reporter assay//Western blot | Functional MTI | 24530397 |
ID | GO ID | GO Term | GO Type |
---|---|---|---|
100 | GO:0001829 | trophectodermal cell differentiation | GOTERM_BP_DIRECT |
100 | GO:0001890 | placenta development | GOTERM_BP_DIRECT |
100 | GO:0032261 | purine nucleotide salvage | GOTERM_BP_DIRECT |
100 | GO:0033089 | positive regulation of T cell differentiation in thymus | GOTERM_BP_DIRECT |
100 | GO:0043278 | response to morphine | GOTERM_BP_DIRECT |
100 | GO:0045987 | positive regulation of smooth muscle contraction | GOTERM_BP_DIRECT |
100 | GO:0046101 | hypoxanthine biosynthetic process | GOTERM_BP_DIRECT |
100 | GO:0005886 | plasma membrane | GOTERM_CC_DIRECT |
100 | GO:0016020 | membrane | GOTERM_CC_DIRECT |
100 | GO:0030054 | cell junction | GOTERM_CC_DIRECT |
100 | GO:0001889 | liver development | GOTERM_BP_DIRECT |
100 | GO:0002906 | negative regulation of mature B cell apoptotic process | GOTERM_BP_DIRECT |
100 | GO:0006154 | adenosine catabolic process | GOTERM_BP_DIRECT |
100 | GO:0042542 | response to hydrogen peroxide | GOTERM_BP_DIRECT |
100 | GO:0043103 | hypoxanthine salvage | GOTERM_BP_DIRECT |
100 | GO:0046638 | positive regulation of alpha-beta T cell differentiation | GOTERM_BP_DIRECT |
100 | GO:0048541 | Peyer's patch development | GOTERM_BP_DIRECT |
100 | GO:0048566 | embryonic digestive tract development | GOTERM_BP_DIRECT |
100 | GO:0060407 | negative regulation of penile erection | GOTERM_BP_DIRECT |
100 | GO:0070244 | negative regulation of thymocyte apoptotic process | GOTERM_BP_DIRECT |
100 | GO:0001883 | complement component C1q binding | GOTERM_MF_DIRECT |
100 | GO:0005615 | extracellular space | GOTERM_CC_DIRECT |
100 | GO:0005764 | lysosome | GOTERM_CC_DIRECT |
100 | GO:0005829 | cytosol | GOTERM_CC_DIRECT |
100 | GO:0009897 | external side of plasma membrane | GOTERM_CC_DIRECT |
100 | GO:0001666 | response to hypoxia | GOTERM_BP_DIRECT |
100 | GO:0002314 | germinal center B cell differentiation | GOTERM_BP_DIRECT |
100 | GO:0002636 | positive regulation of germinal center formation | GOTERM_BP_DIRECT |
100 | GO:0002686 | negative regulation of leukocyte migration | GOTERM_BP_DIRECT |
100 | GO:0006157 | deoxyadenosine catabolic process | GOTERM_BP_DIRECT |
100 | GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | GOTERM_BP_DIRECT |
100 | GO:0010460 | positive regulation of heart rate | GOTERM_BP_DIRECT |
100 | GO:0033197 | response to vitamin E | GOTERM_BP_DIRECT |
100 | GO:0042110 | T cell activation | GOTERM_BP_DIRECT |
100 | GO:0042323 | negative regulation of circadian sleep/wake cycle | GOTERM_BP_DIRECT |
100 | GO:0043101 | purine-containing compound salvage | GOTERM_BP_DIRECT |
100 | GO:0046103 | inosine biosynthetic process | GOTERM_BP_DIRECT |
100 | GO:0050728 | negative regulation of inflammatory response | GOTERM_BP_DIRECT |
100 | GO:0050862 | positive regulation of T cell receptor signaling pathway | GOTERM_BP_DIRECT |
100 | GO:0004000 | acyl-CoA dehydrogenase activity | GOTERM_MF_DIRECT |
100 | GO:0005515 | protein binding | GOTERM_MF_DIRECT |
100 | GO:0008270 | zinc ion binding | GOTERM_MF_DIRECT |
100 | GO:0019239 | kinase regulator activity | GOTERM_MF_DIRECT |
100 | GO:0009986 | cell surface | GOTERM_CC_DIRECT |
100 | GO:0032839 | dendrite cytoplasm | GOTERM_CC_DIRECT |
100 | GO:0043025 | neuronal cell body | GOTERM_CC_DIRECT |
100 | GO:0060205 | cytoplasmic membrane-bounded vesicle lumen | GOTERM_CC_DIRECT |
100 | GO:0001821 | histamine secretion | GOTERM_BP_DIRECT |
100 | GO:0007568 | aging | GOTERM_BP_DIRECT |
100 | GO:0030890 | positive regulation of B cell proliferation | GOTERM_BP_DIRECT |
100 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin | GOTERM_BP_DIRECT |
100 | GO:0042493 | response to drug | GOTERM_BP_DIRECT |
100 | GO:0046061 | dATP catabolic process | GOTERM_BP_DIRECT |
100 | GO:0046111 | xanthine biosynthetic process | GOTERM_BP_DIRECT |
100 | GO:0048286 | lung alveolus development | GOTERM_BP_DIRECT |
100 | GO:0050850 | positive regulation of calcium-mediated signaling | GOTERM_BP_DIRECT |
100 | GO:0060169 | negative regulation of adenosine receptor signaling pathway | GOTERM_BP_DIRECT |
100 | GO:0070256 | negative regulation of mucus secretion | GOTERM_BP_DIRECT |
100 | GO:0005737 | cytoplasm | GOTERM_CC_DIRECT |
Protein Official Symbol | Human Entrez ID | Disease Name | Disease Id | Disease Semantic Type | Semantic score | DSI | DPI | Disease Type |
---|---|---|---|---|---|---|---|---|
ADA | 100 | Autistic Disorder | C0004352 | Mental or Behavioral Dysfunction | 0.34 | 0.494 | 0.793 | group |
ADA | 100 | Spinal Cord Diseases | C0037928 | Disease or Syndrome | 0.3 | 0.494 | 0.793 | group |
ADA | 100 | Liver Cirrhosis, Experimental | C0023893 | Experimental Model of Disease | 0.3 | 0.494 | 0.793 | disease |
ADA | 100 | Lung Neoplasms | C0024121 | Neoplastic Process | 0.3 | 0.494 | 0.793 | group |
ADA | 100 | Reactive Hyperemia | C0178824 | Pathologic Function | 0.3 | 0.494 | 0.793 | phenotype |
ADA | 100 | Malignant neoplasm of lung | C0242379 | Neoplastic Process | 0.3 | 0.494 | 0.793 | disease |
ADA | 100 | Active Hyperemia | C0333233 | Pathologic Function | 0.3 | 0.494 | 0.793 | phenotype |
ADA | 100 | Venous Engorgement | C0042484 | Pathologic Function | 0.3 | 0.494 | 0.793 | phenotype |
ADA | 100 | Hyperemia | C0020452 | Disease or Syndrome | 0.31 | 0.494 | 0.793 | disease |
ADA | 100 | Severe combined immunodeficiency due to adenosine deaminase deficiency | C0392607 | Disease or Syndrome | 0.7 | 0.494 | 0.793 | disease |
ADA | 100 | Partial adenosine deaminase deficiency | C1863239 | Disease or Syndrome | 0.63 | 0.494 | 0.793 | disease |
ADA | 100 | Adenosine deaminase deficiency | C0268124 | Disease or Syndrome | 0.6 | 0.494 | 0.793 | disease |
ADA | 100 | Omenn Syndrome | C2700553 | Disease or Syndrome | 0.31 | 0.494 | 0.793 | disease |
ADA | 100 | Pancreatic Ductal Adenocarcinoma | C1335302 | Neoplastic Process | 0.3 | 0.494 | 0.793 | disease |
ADA | 100 | SCID Due to ADA Deficiency, Early-Onset | C1863236 | Disease or Syndrome | 0.4 | 0.494 | 0.793 | disease |
Protein Official Symbol | Human Entrez ID | drug_claim_primary_name | drug_name | drug_chembl_id | interaction_types |
---|---|---|---|---|---|
ADA | 100 | 2,3-DIDEOXYADENOSINE | CHEMBL23094 | CHEMBL23094 | None |
ADA | 100 | 6-METHYLMERCAPTOPURINE RIBOSIDE | None | None | None |
ADA | 100 | AMITRIPTYLINE | AMITRIPTYLINE | CHEMBL629 | None |
ADA | 100 | ANTIMALARIALS | CHEMBL1255648 | CHEMBL1255648 | None |
ADA | 100 | CLADRIBINE | CLADRIBINE | CHEMBL1619 | inhibitor |
ADA | 100 | CHELATORS | None | None | None |
ADA | 100 | COBALT | None | None | None |
ADA | 100 | DIFFERENTIATING AGENTS | None | None | None |
ADA | 100 | DIPYRIDAMOLE | DIPYRIDAMOLE | CHEMBL932 | None |
ADA | 100 | DIPYRIDAMOLE | DIPYRIDAMOLE | CHEMBL932 | inhibitor |
ADA | 100 | DIPYRIDAMOLE | DIPYRIDAMOLE | CHEMBL932 | None |
ADA | 100 | EHNA | EHNA | CHEMBL50378 | inhibitor |
ADA | 100 | FLUDARABINE | FLUDARABINE | CHEMBL1568 | inhibitor |
ADA | 100 | GARLIC | GARLIC | CHEMBL2108463 | None |
ADA | 100 | H2O2 | HYDROGEN PEROXIDE | CHEMBL71595 | None |
ADA | 100 | HYDROCORTISONE | HYDROCORTISONE | CHEMBL389621 | None |
ADA | 100 | L-DOPA | LEVODOPA | CHEMBL1009 | None |
ADA | 100 | METHOTREXATE | METHOTREXATE | CHEMBL34259 | None |
ADA | 100 | NG-MONOMETHYL-L-ARGININE | TARGININE | CHEMBL256147 | None |
ADA | 100 | PENTOSTATIN | PENTOSTATIN | CHEMBL1580 | inhibitor |
ADA | 100 | PENTOSTATIN | PENTOSTATIN | CHEMBL1580 | inhibitor |
ADA | 100 | PENTOSTATIN | PENTOSTATIN | CHEMBL1580 | None |
ADA | 100 | PENTOSTATIN | PENTOSTATIN | CHEMBL1580 | inhibitor |
ADA | 100 | PENTOSTATIN | PENTOSTATIN | CHEMBL1580 | None |
ADA | 100 | PROTHYMOSIN ALPHA | None | None | None |
ADA | 100 | RECOMBINANT INTERLEUKIN | None | None | None |
ADA | 100 | SELENIUM | None | None | None |